Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period

This study has been terminated.
Information provided by:
Bukwang Pharmaceutical Identifier:
First received: December 19, 2010
Last updated: July 20, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)